BIOMAT Database Logo BIOMAT Database Logo

[Absorption kinetics of semisynthetic human insulin and biosynthetic human insulin]. 1983

F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007657 Ketone Bodies The metabolic substances ACETONE; 3-HYDROXYBUTYRIC ACID; and acetoacetic acid (ACETOACETATES). They are produced in the liver and kidney during FATTY ACIDS oxidation and used as a source of energy by the heart, muscle and brain. Acetone Bodies,Bodies, Acetone,Bodies, Ketone
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
January 1987, Diabetes care,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
[Comparison of 12-month treatment with porcine and human insulin (semisynthetic and biosynthetic)].
September 1986, Minerva medica,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Biosynthetic and semisynthetic rifamycins.
January 1972, Postepy higieny i medycyny doswiadczalnej,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Immunogenicity of semisynthetic human insulin.
January 1986, Acta medica Polona,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
[Comparison of a semisynthetic human insulin and swine insulin].
April 1986, Fortschritte der Medizin,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Biosynthetic human insulin.
January 1982, The Netherlands journal of medicine,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Biosynthetic Human Insulin and Insulin Analogs.
January 2020, American journal of therapeutics,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Evaluation of insulin lispro and biosynthetic human insulin in pulmonary absorption: in vivo and in vitro studies.
August 2012, Die Pharmazie,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations.
January 1983, European journal of clinical pharmacology,
F W Kemmer, and G E Sonnenberg, and H J Cüppers, and M Berger
Immunogenicity of bovine, porcine and semisynthetic human insulin.
January 1985, The Netherlands journal of medicine,
Copied contents to your clipboard!